Pages that link to "Q24680748"
Jump to navigation
Jump to search
The following pages link to The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review (Q24680748):
Displaying 50 items.
- The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy (Q24681141) (← links)
- The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy (Q26827638) (← links)
- Model organisms in the fight against muscular dystrophy: lessons from drosophila and Zebrafish (Q26991681) (← links)
- A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish (Q27322025) (← links)
- Limb-girdle muscular dystrophy (Q28200887) (← links)
- De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. (Q30454132) (← links)
- Dystroglycan modulates the ability of insulin‐like growth factor‐1 to promote oligodendrocyte differentiation (Q34192237) (← links)
- Sensing the environment: a historical perspective on integrin signal transduction (Q34594621) (← links)
- Molecular and comparative genetics of mental retardation (Q34643439) (← links)
- Genetic diseases of muscle (Q34997853) (← links)
- Muscular dystrophy overview: genetics and diagnosis (Q35638579) (← links)
- The muscular dystrophies: from genes to therapies (Q35834674) (← links)
- Recessive LAMC3 mutations cause malformations of occipital cortical development (Q35898589) (← links)
- Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy (Q35952091) (← links)
- Neuronal migration and the role of reelin during early development of the cerebral cortex. (Q36012061) (← links)
- Stroke and Stroke-like Episodes in Muscle Disease (Q36041117) (← links)
- A novel early onset phenotype in a zebrafish model of merosin deficient congenital muscular dystrophy (Q36291506) (← links)
- The congenital muscular dystrophies: recent advances and molecular insights (Q36681282) (← links)
- Congenital muscular dystrophy with inflammation: Diagnostic considerations (Q37167371) (← links)
- Merosin-deficient congenital muscular dystrophy type 1A: A case report (Q37289101) (← links)
- Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects (Q37426320) (← links)
- Consensus statement on standard of care for congenital muscular dystrophies (Q37552615) (← links)
- Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases (Q37589611) (← links)
- Congenital muscular dystrophy type 1A with residual merosin expression. (Q37725152) (← links)
- How factors secreted from astrocytes impact myelin repair (Q37790660) (← links)
- Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies? (Q39010745) (← links)
- Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy (Q41881081) (← links)
- Learning disabilities in neuromuscular disorders: a springboard for adult life (Q42031930) (← links)
- Beta1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. (Q42136039) (← links)
- Novel Mutation (c.8725T>C) in Two Siblings With Late-Onset LAMA2-Related Muscular Dystrophy. (Q42357234) (← links)
- Merosin-deficient congenital muscular dystrophy with cerebral white matter changes: a clue to its diagnosis beyond infancy. (Q42416006) (← links)
- Impeded interaction between Schwann cells and axons in the absence of laminin alpha4. (Q42476607) (← links)
- Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. (Q42489627) (← links)
- Regulation of the blood-testis barrier by a local axis in the testis: role of laminin α2 in the basement membrane. (Q42501409) (← links)
- Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy (Q42754638) (← links)
- ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies (Q45871995) (← links)
- LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies (Q48338116) (← links)
- Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. (Q48467646) (← links)
- Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent (Q48707597) (← links)
- A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese patient. (Q49963380) (← links)
- Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia (Q50507092) (← links)
- Genotype/phenotype analysis in Chinese laminin-α2 deficient congenital muscular dystrophy patients (Q57317698) (← links)
- Laminin α2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice (Q58108925) (← links)
- Newborn blood DNA epigenetic variations and signaling pathway genes associated with Tetralogy of Fallot (TOF) (Q58744139) (← links)
- A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy (Q88457883) (← links)
- Vascular Integrity and Signaling Determining Brain Development, Network Excitability, and Epileptogenesis (Q89620053) (← links)
- LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes (Q90584743) (← links)
- Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A (Q91387651) (← links)
- Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy (Q91906240) (← links)
- Laminin α2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development (Q92350979) (← links)